Pathophysiology of water and sodium retention: Edematous states with normal kidney function

Current Opinion in Pharmacology

Volumn 6, Issue 2, 2006, Pages 202-207

  Bekheirnia, Mir Reza ^a   Schrier, Robert William ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ALBUMIN; ALDOSTERONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; AQUAPORIN 2; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPLERENONE; NORADRENALIN; PROSTAGLANDIN; RELAXIN; SODIUM; SPIRONOLACTONE; TERLIPRESSIN; VASOPRESSIN ANTAGONIST; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR; WATER;

ARTERIAL CIRCULATION; ASCITES; BODY FLUID; EDEMA; EXTRACELLULAR SPACE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART OUTPUT; HEPATORENAL SYNDROME; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER DISEASE; LUNG CONGESTION; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PLASMA RENIN ACTIVITY; PREGNANCY; PRIORITY JOURNAL; REVIEW; SODIUM RETENTION; VASODILATATION; WATER RETENTION;

ATRIAL NATRIURETIC FACTOR; CARDIAC OUTPUT, LOW; EDEMA; FEMALE; HUMANS; KIDNEY; MYOCARDIAL INFARCTION; PREGNANCY; SODIUM;

EID: 33644843464     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.09.008     Document Type: Review

References (41)

1. E.H. Starling Fluids of body: The Harter lectures 1909 Chicago WT Kenner and Co
2. C.I. Johnston J.O. Davis C.A. Robb J.W. Mackenzie Plasma renin in chronic experimental heart failure and during renal sodium "escape"; from mineralocorticoids Circ Res 22 1968 113-125
3. M. Asbert W. Jimenez J. Gaya P. Gines V. Arroyo F. Rivera J. Rodes Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin J Hepatol 15 1992 179-183
4. R.W. Schrier V.A. Briner Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: Implication for pathogenesis of preeclampsia-eclampsia state Obstet Gynecol 77 1991 632-639
5. L.K. Dawbom The effect of prolonged intravenous infusion of aldosterone in a normal human subject Med I Aust 1 1969 1079-1083
6. G. La Villa S.M. Salmeron V. Arroyo J. Bosch P. Gines J.C. Garcia-Pagan A. Gines M. Asbert W. Jimenez F. Rivera et. al. Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension Gastroenterology 102 1992 2114-2119
7. R.W. Schrier O.S. Better Pathogenesis of ascites formation: Mechanism of impaired aldosterone escape in cirrhosis Eur J Gastroenterol Hepatol 3 1991 721-729
8. C.A. Ecelbarger S. Nielsen B.R. Olson T. Murase E.A. Baker M.A. Knepper J.G. Verbalis Role of renal aquaporin in escape from vasopressin-induced antidiuresis in rat J Clin Invest 99 1997 1852-1863
9. Y. Shenker R.S. Sider E.A. Ostafin R.J. Grekin Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema J Clin Invest 76 1985 1684-1687
10. R.J. Cody S.A. Atlas J.H. Laragh S.H. Kubo A.B. Covit K.S. Ryman A. Shaknovich K. Pondolfino M. Clark M.J. Camargo et. al. Atrial natriuretic factor in normal subjects and heart failure patients: Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion J Clin Invest 78 1986 1362-1374
11. P. Gines W. Jimenez V. Arroyo M. Navasa C. Lopez L. Tito A. Serra J. Bosch G. Sanz F. Rivera Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic extraction Hepatology 8 1988 636-642
12. T.R. Morgan T. Imada A.S. Hollister T. Inagami Plasma human atrial natriuretic factor in cirrhosis and ascites with and without functional renal failure Gastroenterology 95 1988 1641-1647
13. P. Angeli L. Caregaro F. Menon D. Sacerdoti R. De Toni C. Merkel A. Gatta Variability of atrial natriuretic peptide plasma levels in ascitic cirrhotics: Pathophysiological and clinical implications Hepatology 16 1992 1389-1394
14. R.W. Schrier Body fluid volume regulation in health and disease: A unifying hypothesis Ann Intern Med 113 1990 155-159
15. H. Kannan R. Yagi Supraoptic neurosecretory neurons: Evidence for the existence of converging inputs both from carotid baroreceptors and osmoreceptors. Brain Res 145 1978 385
16. R.W. Schrier V. Briner C. Caramelo Cellular action and interactions of AVP in vascular smooth muscle: Mechanisms and clinical implications J Am Soc Nephrol 4 1993 2-11
17. R.W. Schrier M. Ohara B. Rogachev L. Xu M. Knotek Aquaporin-2 water channels and vasopressin antagonists in edematous disorders Mole Gen and Metab 65 1998 255-263
18. R.W. Schrier M.A. Cadnapaphornchai M. Ohara Water retention and aquaporins in heart failure, liver disease, and pregnancy J R Soc Med 94 2001 265-269
19. R.W. Schrier M. Cadnapaphornchai Renal aquaporin water channels: From molecules to human disease Prog Biophys Mol Biol 81 2003 17-31
20. R.W. Schrier Y. Chen M.A. Cadnapaphornchai From finch to fish to man: role of aquaporins in body fluid and brain water regulation Neuroscience 129 2004 897-904
21. R.W. Schrier M.A. Cadnapaphornchai F. Umenishi Water-losing and water-retaining states: Role of water channels and vasopressin receptor antagonists Heart Dis 3 2001 210-214
22. J.N. Cohn T.B. Levine M.T. Olivari V. Garberg D. Lura G.S. Francis A.B. Simon T. Rector Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819-823
23. J. Hensen W.T. Abraham J.A. Durr R.W. Schrier Aldosterone in congestive heart failure: Analysis of determinants and role in sodium retention Am J Nephrol 11 1991 441-446
24. W.H. Lee M. Packer Prognostic value of serum sodium concentration in severe heart failure and its modification by converting-enzyme inhibition Circulation 70 1984 113
25. R.W. Schrier W.T. Abraham Hormones and hemodynamics in heart failure N Engl J Med 341 1999 577-585
26. R.W. Schrier A.K. Gurevich M. Cadnapaphornchai Pathogenesis and management of sodium and water retention in cardiac failure and cirrhosis Semin Nephrol 21 2001 157-171
27. R.W. Schrier Role of diminished renal function in cardiovascular mortality: Marker or pathogenetic factor? J Am Coll Cardiol 47 2006 1-8
28. M. Gheorghiade W.A. Gattis C.M. O'Connor K.F. Adams Jr. U. Elkayam A. Barbagelata J.K. Ghali R.L. Benza F.A. McGrew M. Klapholz Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: A randomized controlled trial J Am Med Assoc 291 2004 1963-1971
29. Y. Tsuboi S. Ishikawa G. Fujisawa K. Okada T. Saito Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats Kidney Int 46 1994 237-244
30. P.Y. Martin W.T. Abraham X. Lieming B.R. Olson R.M. Oren M. Ohara R.W. Schrier Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure J Am Soc Nephrol 10 1999 2165-2170
31. P.-Y. Martin D.L. Xu M. Niederberger A. Weigert P. Tsai J. St John P. Gines R.W. Schrier Upregulation of the endothelial constitutive NOS: A major role in the increased NO production in cirrhotic rats Am J Physiol 270 1996 494-499
32. P.-Y. Martin M. Ohara P. Gines D.L. Xu J. St John M. Niederberger R.W. Schrier Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites J Clin Invest 101 1998 235-242
33. R.W. Schrier V. Arroyo M. Bernardi M. Epstein J.H. Henriksen J. Rodes Peripheral arterial vasodilation hypothesis: A proposal for the initial on renal sodium and water retention in cirrhosis Hepatology 8 1988 1151-1157
34. J. Uriz P. Gines A. Cardenas P. Sort W. Jimenez J.M. Salmeron R. Bataller A. Mas M. Navasa V. Arroyo Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome J Hepatol 33 2000 43-48
35. P. Sort M. Navasa V. Arroyo X. Aldeguer R. Planas L. Ruiz-del-Arbol L. Castells V. Vargas G. Soriano M. Guevara et. al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 1999 403-409
36. M.A. Cadnapaphornchai M. Ohara K.G. Morris M. Knotek B. Rogachev T. Ladtkow E.P. Carter R.W. Schrier Chronic nitric oxide synthase inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy Am J Physiol, Renal Phys 280 2001 F592-F598
37. J.B. Whalen C.J. Clancey D.B. Farley D.E. Van Orden Plasma prostaglandins in pregnancy Obstet Gynecol 51 1978 52-55
38. K.P. Conrad A. Jeyabalan L.A. Danielson L.J. Kerchner J. Novak Role of relaxin in maternal renal vasodilation of pregnancy Ann N Y Acad Sci 1041 2005 147-154
39. A.B. Chapman W.T. Abraham S. Zamudio C. Coffin A. Merouani D. Young A. Johnson F. Osorio C. Goldberg L.G. Moore Temporal relationships between hormonal and hemodynamic changes in early human pregnancy Kidney Int 54 1998 2056-2063
40. M. Ohara P.-Y. Martin D.-L. Xu J. St John T.A. Pattison J.K. Kim R.W. Schrier Upregulation of aquaporin-2 water channel expression in pregnant rats J Clin Invest 101 1998 1076-1083
41. R.W. Schrier J.G. Abdallah H.H. Weinberger W.T. Abraham Therapy of heart failure Kidney Int 57 2000 1418-1425